Ir para o conteúdo principal

Little Green Pharma (ASX: LGP) — Perfil da empresa, notícias e dados financeiros

Logo de Little Green Pharma
LGP Little Green Pharma
Little Green Pharma primary media
Perfil da empresa

Little Green Pharma

Little Green Pharma is a global pharmaceutical company specializing in the cultivation, production, and distribution of medical cannabis products. Headquartered in Australia, the company operates GACP-cultivation and GMP-certified manufacturing facilities in Australia and Denmark. Its operations encompass cannabis cultivation, flower processing, oil extraction, formulation, and clinical research. Little Green Pharma supplies a range of prescription medicinal cannabis products, including oral oils, dried flower, and vaporiser devices, to patients across Australia, Europe, and international export markets. The company also conducts observational studies and clinical trials to evaluate therapeutic outcomes and support medical education.

Resumo

Public AUParticipação acionária
2016Ano de fundação
51–200Funcionários
Wembley, AustraliaSede
Carregando mapa...
Presença global

Operações

Todos os locais
Perth, AU
Australia

Produtos e/ou serviços de Little Green Pharma

  • Medicinal Cannabis Oils: Production and supply of broad-spectrum and full-spectrum oral drops and oil formulations with varying ratios of delta-9-tetrahydrocannabinol and cannabidiol, manufactured under Good Manufacturing Practice standards for prescription distribution across Australia and Europe.
  • Dried Cannabis Flower: Cultivation, harvesting, curing, and packaging of pharmaceutical-grade cannabis flower strains, produced at climate-controlled indoor and greenhouse facilities in Denmark and Western Australia for prescription inhalation and vaporisation by medical patients.
  • European Cultivation and Manufacturing Facility: Operation of a large-scale cannabis cultivation and EU-GMP manufacturing asset in Denmark featuring high-volume canopy capacity, automated climate systems, and extraction infrastructure serving primary export markets across Germany, France, and Europe.
  • Australian Production Operations: Management of specialized cultivation and manufacturing infrastructure in Western Australia, handling localized crop cultivation, solvent extraction, product formulation, analytical quality testing, and domestic supply chain logistics for healthcare practitioners.
  • Vaporiser Devices and Inhalation Hardware: Distribution of specialized medical-grade inhalation hardware, cartridges, and vaporisation devices designed to deliver precise dosing of cannabis extracts and botanical formulations to patients under clinical guidance.
  • Clinical Research and Patient Registries: Execution of observational clinical studies and real-world evidence programs, tracking patient treatment outcomes across pain management, neurology, and palliative care to support regulatory approvals and medical practitioner education.

equipe executiva do Little Green Pharma

  • Alistair WarrenCompany Secretary & General Counsel
  • Jason RanceChief Executive Officer of Australia

Comunicados recentes

O que a Little Green Pharma (LGP) comunicou ao mercado, do mais recente para o mais antigo.

  1. Notice of ceasing to be a substantial holder

Principais indicadores financeiros

Resultados divulgados pela Little Green Pharma, em AUD.

Cap. de mercado
49,7 mi
Receita (TTM)
75,5 mi
P/L
—
LPA (diluído, TTM)
0.0
Dividend yield
—
Margem de lucro
4.2%
Receita e lucro anuais da Little Green Pharma
Fim do ano fiscalReceitaResultado operacionalLucro líquido
42,4 mi-2 mi-1,4 mi
36,8 mi-4 mi3,3 mi
25,6 mi-12,2 mi-8,2 mi
19,9 mi-14,5 mi-9,2 mi